| Other Names | diazoxide, 364-98-7, Proglycem, Hyperstat, Hypertonalum, Eudemine, Proglicem, Dizoxide, Mutabase, 7-Chloro-3-methyl-2H-1, 2, 4-benzothiadiazine 1, 1-dioxide, Diazossido, Diazoxido, Diazoxidum, Sch 6783, Sch-6783, SRG 95213, SRG-95213, Eudemine injection, 2H-1, 2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1, 1-dioxide, NSC-64198, Diazoxidum [INN-Latin], Diazoxido [INN-Spanish], NSC 76130, CHEBI:4495, UNII-O5CB12L4FN, EINECS 206-668-1, O5CB12L4FN, MFCD00078578, NSC 64198, NSC-76130, 3-methyl-7-chloro-1, 2, 4-benzothiadiazine 1, 1-dioxide, DTXSID7022914, 7-Cloro-3-metil-2H-1, 2, 4-benzotiodiazina-1, 1-diossido, NSC64198, NSC76130, MLS000028459, DTXCID902914, 364-98-7 (free), 7-chloro-3-methyl-4H-1$l^{6}, 2, 4-benzothiadiazine 1, 1-dioxide, Diazossido [Italian], Diazoxide [USAN:USP:INN:BAN:JAN], 7-Chloro-3-methyl-2H-1, 2, 4-benzothiadiazine1, 1-dioxide, 7-chloro-3-methyl-4h-1, 2, 4-benzothiadiazine 1, 1-dioxide, Diazossido [DCIT], NCGC00015380-09, CAS-364-98-7, SMR000058392, Diazoxidum (INN-Latin), Diazoxido (INN-Spanish), DIAZOXIDE (MART.), DIAZOXIDE [MART.], DIAZOXIDE (USP-RS), DIAZOXIDE [USP-RS], DIAZOXIDE (EP MONOGRAPH), DIAZOXIDE [EP MONOGRAPH], DIAZOXIDE (USP MONOGRAPH), DIAZOXIDE [USP MONOGRAPH], Aroglycem, 7-Chloro-3-methyl-2H-benzo[e][1, 2, 4]thiadiazine 1, 1-dioxide, Diazoxide (USAN:USP:INN:BAN:JAN), Hyperstat (TN), SR-01000075314, 7-Chloro-3-methyl-2H-1, 4-benzothiadiazine 1, 1-dioxide, Diazoxide (JAN/USP/INN), Eudimine, 2H-1, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1, 1-dioxide, 7-Cloro-3-metil-2H-1, 2, 4-benzotiodiazina-1, 1-diossido [Italian], Proglycem (TN), Prestwick_163, Diazoxide (Standard), Diazoxide Oral Solution, Tocris-0964, DIAZOXIDE [INN], DIAZOXIDE [JAN], Opera_ID_608, DIAZOXIDE [MI], DIAZOXIDE [USAN], Diazoxide Oral Suspension, Prestwick0_000087, Prestwick1_000087, Prestwick2_000087, Prestwick3_000087, Spectrum3_000735, Spectrum4_001248, DIAZOXIDE [VANDF], Lopac-D-9035, CHEMBL181, D 9035, DIAZOXIDE [WHO-DD], DIAZOXIDE [WHO-IP], CBiol_001750, Lopac0_000404, SCHEMBL41254, BSPBio_000014, BSPBio_001307, BSPBio_002290, KBioGR_000027, KBioGR_001776, KBioSS_000027, MLS001076071, MLS001424164, SPECTRUM2300206, SPBio_001953, BPBio1_000016, GTPL2409, DIAZOXIDE [ORANGE BOOK], CHEMBL1518123, BDBM86248, HY-B1140R, KBio2_000027, KBio2_002595, KBio2_005163, KBio3_000053, KBio3_000054, KBio3_001510, C02DA01, V03AH01, DIAZOXIDUM [WHO-IP LATIN], 7-chloro-3-methyl-4h-1, E6, 2, 4-benzothiadiazine 1, 1-dioxide, Bio1_000036, Bio1_000525, Bio1_001014, Bio2_000027, Bio2_000507, HMS1361B09, HMS1568A16, HMS1791B09, HMS1922L22, HMS1989B09, HMS2051P20, HMS2089L04, HMS2093N12, HMS2095A16, HMS2234B23, HMS3261A10, HMS3267I11, HMS3371L13, HMS3393P20, HMS3402B09, HMS3411L18, HMS3675L18, HMS3712A16, HMS3885H12, Pharmakon1600-02300206, 2H-1, 2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1, 1-dioxide, 7-Chloro-3-methyl-1lambda~4~, 2, 4-benzothiadiazin-1-ol 1-oxide, 7-chloro-3-methyl-4H-1lambda6, 2, 4-benzothiadiazine 1, 1-dioxide, BCP26107, HY-B1140, NSC_3019, Tox21_110132, Tox21_500404, BDBM50237612, HB0244, KC-115, NSC759574, s4630, AKOS015896340, AKOS024458715, Tox21_110132_1, CCG-101062, CCG-204497, CS-4745, DB01119, FD21519, KS-1444, LP00404, NC00312, NSC-759574, SDCCGSBI-0050390.P002, IDI1_033777, Diazoxide 100 microg/mL in Acetonitrile, NCGC00015380-01, NCGC00015380-02, NCGC00015380-03, NCGC00015380-04, NCGC00015380-05, NCGC00015380-06, NCGC00015380-07, NCGC00015380-08, NCGC00015380-10, NCGC00015380-11, NCGC00015380-12, NCGC00015380-13, NCGC00015380-20, NCGC00022882-03, NCGC00024907-01, NCGC00024907-02, NCGC00024907-03, NCGC00024907-04, NCGC00024907-05, NCGC00024907-06, NCGC00024907-07, NCGC00024907-08, NCGC00261089-01, CAS_364-98-7, SY066792, DB-048966, D5402, EU-0100404, NS00008680, VU0239714-6, C06949, D00294, EN300-122611, F12855, Q420009, SR-01000075314-1, SR-01000075314-3, SR-01000075314-4, SR-01000075314-6, 3-methyl-7-chloro-1, 2, 4-benzothiadiazine1, 1-dioxide, BRD-K73109821-001-05-2, BRD-K73109821-001-10-2, BRD-K73109821-001-19-3, BRD-K73109821-001-20-1, Z1269122570, Diazoxide, European Pharmacopoeia (EP) Reference Standard, 4H-1, 2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1, 1-dioxide, 7-chloro-3-methyl-2H-1lambda6, 2, 4-benzothiadiazine-1, 1-dione, 7-chloro-3-methyl-4H-benzo[e][1, 2, 4]thiadiazine 1, 1-dioxide, Diazoxide, United States Pharmacopeia (USP) Reference Standard, 7-chloro-3-methyl-2H-1$l^{6}, 2, 4-benzothiadiazine 1, 1-dioxide, 7-chloro-3-methyl-4H-1$l^{6}, 2, 4-benzothiadiazine-1, 1-dione, 206-668-1 |
|---|---|
| IUPAC Name | 7-chloro-3-methyl-4H-1lambda6, 2, 4-benzothiadiazine 1, 1-dioxide |
| CAS | 104987-11-3 |
| Molecular Weight | 230.67 |
| Molecular Formula | C8H7ClN2O2S |
| SMILES | CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl |

![(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone - (104987-11-3)](https://eontrading.uk/wp-content/uploads/2025/04/104987-11-3.png)
![1H-Pyrrolo[2,3-b]pyridine, 3-iodo-4-nitro- - (1000340-40-8)](https://eontrading.uk/wp-content/uploads/2025/04/1000340-40-8.png)
![1H-Pyrrolo[2,3-b]pyridine, 3-bromo-4-chloro- - (1000340-39-5)](https://eontrading.uk/wp-content/uploads/2025/04/1000340-39-5.png)
![1H-Pyrrolo[2,3-b]pyridin-3-amine, 4-chloro- - (1000340-38-4)](https://eontrading.uk/wp-content/uploads/2025/04/1000340-38-4.png)

